Upjohn Study: Xanax Impairs Recovery from Panic Disorder and Agoraphobia
Dr. Isaac Marks and Dr. Richard Swinson led a study to determine the efficacy of the benzodiazepine class drug, alprazolam, marketed under the brand name, Xanax, by its developer, Upjohn. The Marks and Swinson study…